<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02875717</url>
  </required_header>
  <id_info>
    <org_study_id>2015-0662/PB_2016-00897</org_study_id>
    <nct_id>NCT02875717</nct_id>
  </id_info>
  <brief_title>Influence of Acetylsalicylic Acid and Low Molecular Weight Heparins on the Incidence of Renal Hematoma of Shockwave Lithotripsy</brief_title>
  <official_title>Influence of Acetylsalicylic Acid and Low Molecular Weight Heparins on the Incidence of Renal Hematoma of Shockwave Lithotripsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kantonsspital Winterthur KSW</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kantonsspital Winterthur KSW</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospective Analysis of patients that received shockwave lithotripsy as Treatment of
      ureteral or kidney Stones. Condition examinated is the effect of low molecular weight
      Heparins and acetylsalicylic acid on the Formation of renal hematoma after shockwave
      lithotripsy. Primary outcome is documented hematoma in a postoperative ultrasound control.
      Secondary outcomes are perioperative complication, Need for erythrocyte tranfusion,
      interventions for bleeding control, readmission or death within 30 days.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Renal Hematoma in ultrasound control</measure>
    <time_frame>first day after intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intervention for bleeding control</measure>
    <time_frame>30 days after intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for erythrocyte concentrate tranfusion</measure>
    <time_frame>30 days after intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death</measure>
    <time_frame>30 days after intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital readmission</measure>
    <time_frame>30 days after intervention</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">500</enrollment>
  <condition>Urolithiasis</condition>
  <condition>Renal Hematoma</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Acetylsalicylic acid</arm_group_label>
    <description>Patients that were on medication with Acetylsalicylic acid on the date of shockwave lithotripsy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low Molecular weight heparin</arm_group_label>
    <description>Patients that were on medication with low molecular heparin on the date of shockwave lithotripsy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetylsalicylic acid</intervention_name>
    <arm_group_label>Acetylsalicylic acid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>low molecular weight heparin</intervention_name>
    <arm_group_label>Low Molecular weight heparin</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients that received shockwave lithotripsy at Kantonsspital Winterthur between
        January 2009 and September 2015 and were 18 years or older at the time of treatment
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  consent

          -  Stones in kidney and proximal Ureter

          -  Treatment with shockwave lithotripsy for urolithiasis between January 2009 and
             September 2015 at Kantonsspital Winterthur

        Exclusion Criteria:

          -  other Position of ureteral Stones

          -  missing data in Patient reports

          -  refused consent

          -  under Age limit
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hubert John, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kantonsspital Winterthur KSW</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kantonsspital Winterthur</name>
      <address>
        <city>Winterhur</city>
        <state>Kanton ZÃ¼rich</state>
        <zip>8401</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 18, 2016</study_first_submitted>
  <study_first_submitted_qc>August 18, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 23, 2016</study_first_posted>
  <last_update_submitted>August 18, 2016</last_update_submitted>
  <last_update_submitted_qc>August 18, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 23, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kantonsspital Winterthur KSW</investigator_affiliation>
    <investigator_full_name>Christoph Schregel</investigator_full_name>
    <investigator_title>Resident</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hematoma</mesh_term>
    <mesh_term>Urolithiasis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium heparin</mesh_term>
    <mesh_term>Heparin</mesh_term>
    <mesh_term>Heparin, Low-Molecular-Weight</mesh_term>
    <mesh_term>Dalteparin</mesh_term>
    <mesh_term>Aspirin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

